NVAX
Novavax Inc
10.50$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -146.1% | – | – | – | – | -136.6% | – | – | – | |
| – | -4.7% | +12.5% | -8.4% | +14.1% | -1.4% | -33.4% | -9.3% | -12.9% | -22.2% | -40.3% | -0.2% | – | |
| – | -24.6% | -26.2% | +22.0% | -14.5% | -13.3% | -1.6% | -10.4% | -7.2% | -6.8% | -3.1% | +4.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -212.8% | – | +236.3% | -145.4% | – | – | – | – | -144.4% | – | – | – | |
| – | -50.6% | -20.1% | -56.9% | -35.6% | +11.9% | -29.2% | -84.5% | +716.6% | +2.9% | -38.8% | +0.0% | – | |
| – | -50.6% | -20.1% | +5,040.8% | – | +351.3% | -150.9% | – | -222.9% | – | -238.5% | – | – | |
| – | – | – | – | – | – | – | – | – | -140.2% | +2,372.1% | – | – | |
| – | – | – | – | – | +438.3% | -20.1% | -72.2% | – | -115.1% | – | -202.4% | – | |
| – | -49.1% | -94.1% | +4,287.0% | -100.0% | +3,427.8% | +106.3% | -85.3% | – | -115.6% | – | -75.2% | – | |
| – | -155.6% | – | – | -153.6% | – | – | – | – | -290.3% | – | – | – | |
| – | – | – | – | -147.2% | – | – | – | – | -139.3% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.